SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 11, 2003
VAXGEN, INC.
(Exact name of Registrant as Specified in its Charter)
DELAWARE 0-26483 94-3236309
(State or other (Commission (I.R.S. Employer
jurisdiction of File Number) incorporation or
Identification Number) organization)
1000 MARINA BLVD., SUITE 200 BRISBANE, CALIFORNIA 94005
(Address of Principal Administrative Offices)
Registrants Telephone Number, Including Area Code: (650) 624-1000
Item 5. Other Events.
On February 11, 2003, VaxGen, Inc. released its financial results for the fourth
quarter and year ended December 31, 2002.
The press release is filed herewith as Exhibit 99.1 and incorporated herein by
reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
EXHIBIT DESCRIPTION
99.1 Press Release issued February 11, 2003.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
VaxGen, Inc.
(Registrant)
Dated: February 13, 2003 By: /s/ Carter A. Lee
---------------------------
Carter A. Lee
Senior Vice President
Finance & Administration
EXHIBIT INDEX
EXHIBIT No. DESCRIPTION
99.1 Press Release issued February 11, 2003.